The expression of metallothionein (MT) and proliferation intensity in ovarian cancers treated with cisplatin and paclitaxel

Folia Morphologica

Volumn 62, Issue 4, 2003, Pages 493-495

  Surowiak, Paweł ^a,b   Kaplenko, Irina ^a   Spaczyński, Marek ^a   Zabel, Maciej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cisplatin; Metallothionein; Ovarian cancer; Paclitaxel; Proliferation

Indexed keywords

ALKYLATING AGENT; CISPLATIN; CYCLINE; HEAVY METAL; KI 67 ANTIGEN; METALLOTHIONEIN; MONOCLONAL ANTIBODY KI 67; PACLITAXEL; PARAFFIN; PROTEIN ANTIBODY;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CELL CYCLE; CELL PROLIFERATION; CELL PROTECTION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MOLECULAR WEIGHT; MULTIDRUG RESISTANCE; OVARY CANCER; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SECOND LOOK SURGERY; STATISTICAL ANALYSIS; TISSUE SECTION;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL COUNT; CELL DIVISION; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; METALLOTHIONEIN; OVARIAN NEOPLASMS; PACLITAXEL; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

FALLOPIA;

EID: 0346783347     PISSN: 00155659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hagrman D, Goodisman J, Dabrowiak JC, Souid AK (2003) Kinetic study on the reaction of cisplatin with metallothionein. Drug Metab Dispos, 31: 916-923.
2. Hengstler JG, Pilch H, Schmidt M, Dahlenburg H, Sagemuller J, Schiffer I, Oesch F, Knapstein PG, Kaina B, Tanner B (2001) Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis. Int J Cancer, 95: 121-127.
3. Kagi JHR (1991) Overview of metallothionein. Methods Enzymol, 205: 613-626.
4. Markman M (2003) Optimizing primary chemotherapy in ovarian cancer. Hematol Oncol Clin North Am, 17: 957-968.
5. Markowska J (ed.) Rak jajnika. Springer PWN, Warszawa 1997.
6. Remmele W, Stenger HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ERICA) in breast cancer tissue. Pathologe, 8: 138-140.